BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37944834)

  • 1. Ginsenoside Rh1, a novel casein kinase II subunit alpha (CK2α) inhibitor, retards metastasis via disrupting HHEX/CCL20 signaling cascade involved in tumor cell extravasation across endothelial barrier.
    Zheng W; Shen P; Yu C; Tang Y; Qian C; Yang C; Gao M; Wu Y; Yu S; Tang W; Wan G; Wang A; Lu Y; Zhao Y
    Pharmacol Res; 2023 Dec; 198():106986. PubMed ID: 37944834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
    Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
    Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of CCL20-CCR6 Axis in Ovarian Cancer Metastasis.
    Liu W; Wang W; Zhang N; Di W
    Onco Targets Ther; 2020; 13():12739-12750. PubMed ID: 33335408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes.
    Zou J; Luo H; Zeng Q; Dong Z; Wu D; Liu L
    J Transl Med; 2011 Jun; 9():97. PubMed ID: 21702981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
    Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
    Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.
    Xie T; Fu DJ; Li ZM; Lv DJ; Song XL; Yu YZ; Wang C; Li KJ; Zhai B; Wu J; Feng NH; Zhao SC
    Mol Cancer; 2022 Sep; 21(1):173. PubMed ID: 36045408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CCR6 in esophageal squamous cell carcinoma and its effects on epithelial-to-mesenchymal transition.
    Liu J; Zheng X; Deng H; Xu B; Chen L; Wang Q; Zhou Q; Zhang D; Wu C; Jiang J
    Oncotarget; 2017 Dec; 8(70):115244-115253. PubMed ID: 29383156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortactin Phosphorylation by Casein Kinase 2 Regulates Actin-Related Protein 2/3 Complex Activity, Invadopodia Function, and Tumor Cell Invasion.
    Markwell SM; Ammer AG; Interval ET; Allen JL; Papenberg BW; Hames RA; Castaño JE; Schafer DA; Weed SA
    Mol Cancer Res; 2019 Apr; 17(4):987-1001. PubMed ID: 30610108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive Effects of Ginsenoside Rh1 on HMGB1-Mediated Septic Responses.
    Lee W; Cho SH; Kim JE; Lee C; Lee JH; Baek MC; Song GY; Bae JS
    Am J Chin Med; 2019; 47(1):119-133. PubMed ID: 30630344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CCL20-CCR6 Axis in Cancer Progression.
    Kadomoto S; Izumi K; Mizokami A
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rh1 protects human endothelial cells against lipopolysaccharide-induced inflammatory injury through inhibiting TLR2/4-mediated STAT3, NF-κB, and ER stress signaling pathways.
    Jin Y; Nguyen TLL; Myung CS; Heo KS
    Life Sci; 2022 Nov; 309():120973. PubMed ID: 36150463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils for Revascularization Require Activation of CCR6 and CCL20 by TNFα.
    Lörchner H; Cañes Esteve L; Góes ME; Harzenetter R; Brachmann N; Gajawada P; Günther S; Doll N; Pöling J; Braun T
    Circ Res; 2023 Sep; 133(7):592-610. PubMed ID: 37641931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A High-Content Screen Identifies Drugs That Restrict Tumor Cell Extravasation across the Endothelial Barrier.
    Hilfenhaus G; Mompeón A; Freshman J; Prajapati DP; Hernandez G; Freitas VM; Ma F; Langenbacher AD; Mirkov S; Song D; Cho BK; Goo YA; Pellegrini M; Chen JN; Damoiseaux R; Iruela-Arispe ML
    Cancer Res; 2021 Feb; 81(3):619-633. PubMed ID: 33218969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference (RNAi) mediated stable knockdown of protein casein kinase 2-alpha (CK2α) inhibits migration and invasion and enhances cisplatin-induced apoptosis in HEp-2 laryngeal carcinoma cells.
    Zhang F; Yang B; Shi S; Jiang X
    Acta Histochem; 2014 Jul; 116(6):1000-6. PubMed ID: 24831064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
    Brand S; Olszak T; Beigel F; Diebold J; Otte JM; Eichhorst ST; Göke B; Dambacher J
    J Cell Biochem; 2006 Mar; 97(4):709-23. PubMed ID: 16215992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rh1 Induces MCF-7 Cell Apoptosis and Autophagic Cell Death through ROS-Mediated Akt Signaling.
    Huynh DTN; Jin Y; Myung CS; Heo KS
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CCL20/CCR6 and the ERK signaling pathway in lung adenocarcinoma.
    Zhang XP; Hu ZJ; Meng AH; Duan GC; Zhao QT; Yang J
    Oncol Lett; 2017 Dec; 14(6):8183-8189. PubMed ID: 29250193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rh1 Prevents Migration and Invasion through Mitochondrial ROS-Mediated Inhibition of STAT3/NF-κB Signaling in MDA-MB-231 Cells.
    Jin Y; Huynh DTN; Myung CS; Heo KS
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress.
    Meissner A; Zilles O; Varona R; Jozefowski K; Ritter U; Marquez G; Hallmann R; Korner H
    Blood; 2003 Oct; 102(8):2724-7. PubMed ID: 12816871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.
    Kano H; Izumi K; Hiratsuka K; Toriumi R; Nakagawa R; Aoyama S; Kamijima T; Shimada T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Nohara T; Shigehara K; Kadono Y; Saito Y; Nakagawa-Goto K; Yoshioka K; Nakata H; Lin WJ; Mizokami A
    Cancer Sci; 2023 Apr; 114(4):1479-1490. PubMed ID: 36479732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.